Endoneurial capillary abnormalities presage deterioration of glucose tolerance and accompany peripheral neuropathy in man

Diabetes

Volumn 52, Issue 10, 2003, Pages 2615-2622

  Thrainsdottir, Soley ^a   Malik, Rayez A ^b   Dahlin, Lars B ^a   Wiksell, Peter ^a   Eriksson, Karl F ^a   Rosén, Ingmar ^a   Petersson, Jesper ^a   Greene, Douglas A ^c   Sundkvist, Göran ^a,d  

^a LUND UNIVERSITY   (Sweden)

^b MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

ADULT; AGED; ARTICLE; CAPILLARY BASEMENT MEMBRANE; CAPILLARY DENSITY; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC ANGIOPATHY; DIABETIC NEUROPATHY; DISEASE ACTIVITY; DISEASE COURSE; FOLLOW UP; GLUCOSE TOLERANCE TEST; HUMAN; HUMAN TISSUE; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; NERVE FIBER MEMBRANE; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL;

CAPILLARIES; DIABETES MELLITUS; DIABETIC ANGIOPATHIES; DIABETIC NEUROPATHIES; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; MALE; MICROSCOPY, ELECTRON; MIDDLE AGED; PERIPHERAL NERVOUS SYSTEM DISEASES; SURAL NERVE;

EID: 0141755309     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.52.10.2615     Document Type: Article

References (41)

1. Dyck PJ, Kratz KM, Karnes JL, Litchy WJ, Klein R, Pach JM, Wilson DM, O'Brien PC, Melton LJ III: The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology 43:817-824, 1993
2. Fedele D, Comi G, Coscelli C, Cucinotta D, Feldman EL, Ghirlanda G, Greene DA, Negrin P, Santeusiano F, the Italian Diabetic Neuropathy Committee: A multicenter study on the prevalence of diabetic neuropathy in Italy. Diabetes Care 20:836-842, 1997
3. Forsblom CM, Sane T, Groop PH, Totterman KJ, Kallio M, Saloranta C, Laasonen L, Summanen P, Lepantalo M, Laatikainen L, Matikainen E, Teppo AM, Koskimies S, Groop L: Risk factors for mortality in type II (non-insulin-dependent) diabetes: evidence of a role for neuropathy and a protective effect of HLA-DR4. Diabetologia 41:1253-1262, 1998
4. Abbott CA, Carrington AL, Ashe H, Bath S, Every LC, Griffiths J, Hann AW, Hussein A, Jackson N, Johnson KE, Ryder CH, Torkington R, Van Ross ER, Whalley AM. Widdows P, Williamson S, Boulton AJ: The North-West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort. Diabet Med 19:377-384, 2002
5. The Diabetes Control and Complications Trial Research Group: The effect of intensive diabetes therapy on the development and progression of neuropathy. Arch Intern Med 122:561-568, 1995
6. Singleton JR, Smith AG, Bromberg MB: Painful sensory polyneuropathy associated with impaired glucose tolerance. Muscle Nerve 24:1225-1228, 2001
7. Smith AG, Ramachandran P, Tripp S, Singleton JR: Epidermal nerve innervation in impaired glucose tolerance and diabetes-associated neuropathy. Neurology 57:1701-1704, 2001
8. Novella SP, Inzucchi SE, Goldstein JM: The frequency of undiagnosed diabetes and impaired glucose tolerance in patients with idiopathic sensory neuropathy. Muscle Nerve 24:1229-1231, 2001
9. Sumner CJ, Sheth S, Griffin JW, Cornblath DR, Polydefkis M: The spectrum of neuropathy in diabetes and impaired glucose tolerance. Neurology 60:108-111, 2003
10. Sundkvist G, Dahlin L-B, Nilsson H, Eriksson K-F, Lindgärde F, Rosén I, Lattimer S, Sima AAF, Sullivan K, Greene DA: Sorbitol and myo-inositol levels and morphology of sural nerve in relation to peripheral nerve function and clinical neuropathy in men with diabetic, impaired, and normal glucose tolerance. Diabet Med 17:259-268, 2000
11. West IC: Radicals and oxidative stress in diabetes. Diabet Med 17:171-180, 2000
12. King GL, Ishii H, Koya D: Diabetic vascular dysfunctions: a model of excessive activation of protein kinase C. Kidney Int Supp 60:S77-S85, 1997
13. Airey M, Bennett C, Nicolucci A, Williams R: Aldose reductase inhibitors for the prevention and treatment of diabetic peripheral neuropathy [CD-ROM]. Cochrane Database Syst Rev CD002182, 2000
14. Greene DA, Arezzo JC, Brown MB, Zenarestat Study Group: Effect of aldose reductase inhibition on nerve conduction and morphometry in diabetic neuropathy. Neurology 53:580-591, 1999
15. Fagerberg S-E: Diabetic neuropathy: a clinical and histological study on the significance of vascular affections. Acta Med Scand 164 (Suppl. 345):1-109, 1959
16. Giannini C, Dyck PJ: Basement membrane reduplication and pericyte degeneration precede development of diabetic polyneuropathy and are associated with its severity. Ann Neurol 37:498-504, 1995
17. Malik RA, Tesfaye S, Thompson SD, Veves A, Sharma AK, Boulton AJ, Ward JD: Endoneurial localisation of microvascular damage in human diabetic neuropathy. Diabetologia 36:454-459, 1993
18. Eriksson KF, Lindgärde F: Impaired glucose tolerance in a middle-aged male urban population: a new approach for identifying high-risk cases. Diabetologia 33:526-531, 1990
19. Eriksson KF, Saltin B, Lindgarde F: Increased skeletal muscle capillary density precedes diabetes development in men with impaired glucose tolerance: a 15-year follow-up. Diabetes 43:805-808, 1994
20. Eriksson KF, Nilsson H, Lindgärde F, Österlin S, Dahlin L-B, Lilja B, Rosén I, Sundkvist G: Diabetes mellitus but not impaired glucose tolerance is associated with dysfunction in peripheral nerves. Diabet Med 11:279-285, 1994
21. Dyck PJ: Detection, characterization, and staging of polyneuropathy: assessed in diabetics. Muscle & Nerve 11:21-32, 1988
22. Alberti KG, Zimmet PZ: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15:539-553, 1998
23. Heding LS: Radioimmunological determination of C-peptide in serum. Diabetologia 11:541-548, 1975
24. Dahlin LB, Eriksson K-F, Sundkvist G: Persistent postoperative complaints after whole sural nerve biopsies in diabetic and non-diabetic subjects. Diabet Med 14:353-356, 1997
25. Malik RA, Masson EA, Sharma AK, Lye RH, Ah-See AK, Compton AM, Tomlinson DR, Hanley SP, Boulton AJM: Hypoxic neuropathy: relevance to human diabetic neuropathy. Diabetologia 33:311-318, 1990
26. Malik RA, Veves A, Masson EA, Sharma AK, Ah-See AK, Schady W, Lye RH, Boulton AJ: Endoneurial capillary abnormalities in mild human diabetic neuropathy. J Neurol Neurosurg Psychiatry 55:557-561, 1992
27. Malik RA, Newrick PG, Sharma AK, Jennings A, Ah-See AK, Mayhew TM, Jakubowski J, Boulton AJ, Ward JD: Microangiopathy in human diabetic neuropathy: relationship between capillary abnormalities and the severity of neuropathy. Diabetologia 32:92-102, 1989
28. Khawaja KI, Walker D, Hayat SA, Boulton AJ, Malik RA: Clinico-pathological features of postural hypotension in diabetic autonomic neuropathy. Diabet Med 17:163-166, 2000
29. Newrick PG, Wilson AJ, Jakubowski J, Boulton AJ, Ward JD: Sural nerve oxygen tension in diabetes. Br Med J (Clin Res Ed) 293:1053-1054, 1986
30. Britland ST, Young RJ, Sharma AK, Clarke BF: Relationship of endoneurial capillary abnormalities to type and severity of diabetic polyneuropathy. Diabetes 39:909-913, 1990
31. Bradley J, Thomas PK, King RHM, Llewelyn JG, Muddle JR, Watkins PJ: Morphometry of endoneurial capillaries in diabetic sensory and autonomic neuropathy. Diabetologia 33:611-618, 1990
32. Tesfaye S, Malik R, Harris N, Jakubowski JJ, Mody C, Rennie IG, Ward JD: Arterio-venous shunting and proliferating new vessels in acute painful neuropathy of rapid glycaemic control (insulin neuritis). Diabetologia 39:329-335, 1996
33. Low PA, Lagerlund TD, McManis PG: Nerve blood flow and oxygen delivery in normal, diabetic, and ischemic neuropathy. Int Rev Neurobiol 31:355-438, 1989
34. Mawrin C, Schutz G, Schroder JM: Correlation between the number of epineurial and endoneurial blood vessels in diseased human sural nerves. Acta Neuropathol (Berl) 102:364-372, 2001
35. Partanen J, Niskanen L, Lehtinen J, Mervaala E, Sitonen O, Uusitupa M: Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 333:89-94, 1995
36. Dyck PJ, Hansen S, Karnes J, O'Brien P, Yasuda H, Windebank A, Zimmerman B: Capillary number and percentage closed in human diabetic sural nerve. Proc Natl Acad Sci U S A 82:2513-2517, 1985
37. Mather K, Anderson TJ, Verma S: Insulin action in the vasculature: physiology and pathophysiology. J Vasc Res 38:415-422, 2001
38. Vincent MA, Dawson D, Clark AD, Lindner JR, Rattigan S, Clark MG, Barrett EJ: Skeletal muscle microvascular recruitment by physiological hyperinsulinemia precedes increases in total blood flow. Diabetes 51:42-48, 2002
39. Baron AD: Insulin resistance and vascular function. J Diabetes Complications 16:92-102, 2002
40. Sugimoto K, Baba M, Suda T, Yagihashi S: Electrophysiology and morphology in the peripheral nerve associated with chronic hyperinsulinemia and hypoglycemia in rats bearing insulinoma (Abstract). Diabetologia (Suppl. 2):A29, 2002
41. Kihara M, Zollman PJ, Smithson IL, Lagerlund TD, Low PA: Hypoxic effect of exogenous insulin on normal and diabetic peripheral nerve. Am J Physiol 266:E980-E985, 1994